CCI has approved the proposals of 360 ONE and Ranjan Pai's Claypond Capital to jointly acquire stakes in healthtech unicorn PharmEasy. Under the proposed transaction, 360 ONE plans to acquire certain class B compulsorily convertible preference shares (CCPS B) of API Holdings, PharmEasy's parent company, from existing shareholder MEMG Family Office LLP. Specific terms of the deal, including size and amount, have not been disclosed.

For more, click here